← all works
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Asthma and respiratory diseases
- Field
- Medicine
- Canadian institutions
- Vancouver General Hospital
- Funders
- AstraZeneca
- Keywords
- BenralizumabMedicineExacerbationPlaceboAsthmaEosinophiliaMepolizumabClinical endpointInternal medicineEosinophilRandomized controlled trialPathology
- Has abstract in OpenAlex
- no